Artificial Intelligence #AI – the new hope for Pharma R&D - By Manishree Bhattacharya @ManishreeBhatt1


Pretty much every article starts with the challenges that pharmaceutical industry across the globe is facing. It is a difficult industry and everybody acknowledges that, considering the time to develop an original drug (10-15 years), the costs involved (last time I checked it was USD 2-3 billion), the high attrition rates of drug candidates (1 out of 5,000 or 10,000 leads make way for FDA approval), the tough regulatory environment which is varied across countries and geographies, and the rising pressures on pricing (pricing advantage for truly outcome-driven therapeutics). All of these, with the looming patent expiry, the imminent entry of generics, and the tantalizing RoIs, make it even more difficult.



Read more »

Blog Series: #IoT in Healthcare by Manishree Bhattacharya @ManishreeBhatt1



The opportunity for #IoT in Healthcare is estimated to be $2.5 trillion by 2025. How are we embracing this change? The Types of Opportunities that present themselves to the Startups, Healthcare IT organisations are tremendous.

During the #PhilipsChat, on the 10th April 2017, we asked the experts what they thought about the current trends and focus areas that the IT Industry, Medical Device Manufacturers, Hospitals and Start-ups will need to keep in view, in the near and short-term, while making their organisation ready for the Digital Transformation that can be and will be enabled by #IoT in Healthcare.  
Presenting the insights shared by Manishree Bhattacharya (@ManishreeBhatt1) on #IoT in Healthcare

Read more »



POPULAR POSTS

Popular Posts